Emergency Dose Selection Models: Principles, Evidence, and Clinical Application

Abstract

Emergency dose selection models are essential tools in acute care, enabling clinicians to determine optimal drug dosing rapidly under critical conditions. These models integrate pharmacokinetic, pharmacodynamic, and patient-specific variables to guide precise, evidence-based dosing decisions. This review synthesizes current scientific knowledge, recent advances, and clinical guidelines, highlighting the mechanisms, epidemiological factors, and practical applications of dose selection models in emergency medicine.

Introduction

In emergency settings, the prompt administration of medications can be lifesaving. Determining the correct dose is complicated by patient variability, limited information, and the urgent nature of interventions. Emergency dose selection models have evolved to address these challenges, combining clinical acumen with computational and evidence-based approaches. This review aims to provide clinicians with a comprehensive understanding of the scientific underpinnings, clinical relevance, and practical use of dose selection models in emergencies, with a focus on the latest research and guideline-based recommendations.

Epidemiology / Disease Burden

The global burden of acute medical emergencies—such as sepsis, cardiac arrest, trauma, and toxicological crises—necessitates rapid decision-making regarding drug administration. According to the World Health Organization, millions of emergency room visits annually involve critical pharmacologic interventions. Inadequate dosing in emergencies can lead to suboptimal outcomes, increased morbidity, or adverse effects. Dose selection errors are implicated in up to 15% of medication-related adverse events in acute care, underscoring the need for robust, validated dosing models in emergency medicine.

Pathophysiology

Emergency situations frequently disrupt normal physiology, altering drug absorption, distribution, metabolism, and excretion. Shock, hypoperfusion, organ dysfunction, and changes in plasma protein binding can impact pharmacokinetics and pharmacodynamics. For instance, critically ill patients may exhibit increased volume of distribution or impaired renal clearance, necessitating adjustments in dosing regimens. Dose selection models must account for these pathophysiological changes to ensure efficacy and minimize toxicity.

Risk Factors

Several patient-specific and situational risk factors influence emergency dose requirements. Age, body weight, comorbidities, hepatic or renal impairment, polypharmacy, and genetic polymorphisms can all affect drug response. In trauma or resuscitation scenarios, factors such as hypovolemia and altered perfusion further complicate dose estimation. Additionally, limited access to laboratory values and patient history in emergencies heightens the need for adaptable, evidence-based models.

Clinical Features

Clinical features of patients requiring emergent pharmacotherapy vary widely, ranging from hemodynamic instability to altered mental status. The urgency of intervention often precludes detailed patient assessment, making empiric dose selection necessary. Models must be adaptable to presenting features—such as airway compromise, shock, or seizure activity—while considering potential drug-drug interactions, allergies, and contraindications. Accurate clinical assessment remains paramount in guiding model-based dose selection.

Diagnosis

Rapid diagnosis is critical for guiding appropriate emergency drug dosing. Point-of-care testing, bedside ultrasonography, and clinical scoring systems aid in identifying underlying pathologies and tailoring interventions. For example, the identification of acute coronary syndrome, anaphylaxis, or status epilepticus determines the urgency and specific medications required, with dose selection models providing structured support for these time-sensitive decisions.

Treatment & Management

Emergency dose selection models guide clinicians in the administration of medications such as vasopressors, antimicrobials, anticoagulants, and antidotes. Models may be rule-based (e.g., weight-based dosing for pediatric resuscitation), algorithmic (e.g., nomograms for acetaminophen toxicity), or utilize computerized decision support. The goal is to optimize therapeutic efficacy while minimizing adverse effects. Iterative assessment and dose adjustment, based on clinical response and emerging data (such as lab results), are integral to acute management.

Recent Advances / Emerging Therapies

Recent advances in emergency dose selection include the integration of pharmacogenomics, machine learning algorithms, and real-time electronic health record (EHR) data. Machine learning models can predict optimal dosing by analyzing large datasets, while pharmacogenomic insights enable individualized drug selection and dosing. Mobile applications and EHR-based clinical decision support tools are being increasingly adopted, enhancing the speed and accuracy of dose selection in real-world emergency settings. Ongoing research is focused on validating these technologies to improve patient outcomes.

Guideline Recommendations

International and national guidelines emphasize the use of validated dose selection models in emergency care. The American Heart Association, European Society of Cardiology, and other bodies recommend specific dosing algorithms for drugs used in resuscitation and acute management. For example, the Broselow Tape remains a standard for pediatric dosing in emergencies. Guidelines advocate for continuous education, simulation-based training, and the adoption of decision support technologies to reduce errors in dose selection and improve clinical outcomes.

Conclusion

Emergency dose selection models are indispensable for delivering safe and effective pharmacotherapy in acute care settings. Advances in computational modeling, pharmacogenomics, and digital health are enhancing the precision and applicability of these models. Clinicians must remain informed of evolving evidence and guidelines to ensure optimal patient care. Ongoing research and integration of emerging technologies hold promise for further improving the accuracy and clinical utility of emergency dose selection tools.